Evozyne

Revolutionizing novel synthetic protein design to solve some of the world’s most complex human and societal challenges.

[Evozyne @evozyne]

Powered by our strategic partnerships, we apply our molecular engineering technology platform to the development of novel proteins in advanced applications, such as new therapeutic approaches in certain rare disorders.

Read more: https://t.co/AcogaSKR6k

[Evozyne @evozyne]

We’ve entered a strategic collaboration and license agreement with @TakedaPharma that will allow us to research and develop proteins that could be incorporated into gene therapies for certain genetic disorders. Read more: https://t.co/5DBKDgIhPe

[Evozyne @evozyne]

Life science innovator @ParagonBiosci created Evozyne with a vision to develop novel proteins faster, more efficiently & more productively to solve important societal problems. Learn more about Paragon’s portfolio of innovative life science companies at https://t.co/6HcYdNRIYg

[Evozyne @evozyne]

The potential our molecular engineering technology platform has and its impact on innovation and growth across a variety of industries is truly impressive. Follow us on #LinkedIn to stay up-to-date on our latest partnerships, publications and team updates: https://t.co/86Sy7diZyA

[Evozyne @evozyne]

Developing novel proteins must be faster, more efficient & more productive to solve societal challenges. A publication in @ScienceMagazine demonstrates the foundation of our data-driven engineering process for building artificial functional enzymes. https://t.co/Xt8lJhJZap

[Evozyne @evozyne]

Evozyne is dedicated to solving the world’s most pressing problems. We’re proud to be headquartered right here in Chicago, a life science hub. https://t.co/LjLgc9MBip

[Evozyne @evozyne]

We’re pleased to welcome Lisa Hochrein, Ph.D., to the Evozyne team as Senior Scientist. Lisa comes to us from @Caltech with more than 15 years of experience in molecular biology and genome engineering.

[Evozyne @evozyne]

Last month Emanuelle Charpentier & Jennifer Doudna received the #NobelPrize in Chemistry for their work on #Crispr-Cas9, a method to edit DNA. Their accomplishments will have a lasting impact on #MolecularEngineering and humankind. https://t.co/Ikv4x2h6TY

[Evozyne @evozyne]

Learn more about our 30,000 sq. ft newly acquired lab space in #Chicago’s Lincoln Park neighborhood in this feature from @LabManager https://t.co/LyA37qezu7 #science #laboratory

[Evozyne @evozyne]

We are leasing 30,000 square feet with @sterlingbay for our growing lab to build synthetic proteins that have the potential to change the world. Life science #innovation is happening here in #Chicago! https://t.co/UF3WyJsaFF

[Evozyne @evozyne]

Our Co-Founder & CSO Rama Ranganathan, MD, PhD, recently presented a free public lecture as part of the @AspenPhysics virtual lecture series to talk about what proteins are and how they work. Access the full lecture here: https://t.co/fhqdGwwQnS

[Evozyne @evozyne]

Big things are happening at Evozyne. So big that we needed a lot more space to meet the growing demand for our synthetic proteins that have the potential to change the world. @chicagotribune #ChicagoInnovation https://t.co/jvaowD6TRW

[Evozyne @evozyne]

We’re finding ways to tackle some of the world’s most challenging societal problems by creating novel proteins with our data-driven molecular engineering technology. Learn more about how we are revolutionizing #protein design: https://t.co/rjyvI2GnJu

[Evozyne @evozyne]

Recently we welcomed Kate Malecek, PhD to our team as a Research Scientist. We look forward to Kate’s expertise as our team continues to address some of the most complex human and societal challenges that exist today. Welcome to Evozyne, Kate!

[Evozyne @evozyne]

Two of our three co-founders Rama Ranganathan, MD, PhD & Andrew Ferguson, PhD, were recognized by the @dreyfusfndn as 2020 Machine Learning in the Chemical Sciences & Engineering award recipients. They are two of many scientific leaders advancing #innovation in #Chicago.

[Evozyne @evozyne]

We’re expanding to a 30,000 sq. ft laboratory in Chicago’s Lincoln Park neighborhood. The lab space supports the demand for our evolution-based, data-driven engineering technology to build synthetic proteins that have the potential to change the world. https://t.co/n7l5Le1xdC

[Evozyne @evozyne]

It was an honor to be selected as a finalist for the Fierce Innovation Award – Life Sciences Edition 2020 in the Technology #Innovation Category and recognized for our work in data-driven molecular engineering. Congratulations to all the nominees and winners! @FierceBiotech

[Evozyne @evozyne]

At Evozyne, we are passionate about data-driven solutions, from molecular scale to global. Our mission is to unlock the potential of novel proteins to solve complex human and societal challenges by revolutionizing protein design. Learn more: https://t.co/0wgmhPznUi